Primary Site >> Biliary tract Cancer

Gene >> CDK20

Journal: Hepatology. 1999 Nov;30(5):1128-33.
Title: Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.
Author: Park, J|Tadlock, L|Gores, G J|Patel, T
PMID: 10534331
Journal: Hepatology. 2001 Jan;33(1):43-51.
Title: Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
Author: Tadlock, L|Patel, T
PMID: 11124819
Journal: Gastroenterology. 2002 Apr;122(4):985-93.
Title: Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.
Author: Yoon, Jung-Hwan|Higuchi, Hajime|Werneburg, Nathan W|Kaufmann, Scott H|Gores, Gregory J
PMID: 11910351
Journal: Hepatology. 2003 May;37(5):1122-9.
Title: Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma.
Author: Tanaka, Shinji|Sugimachi, Keishi|Kameyama, Toshifumi|Maehara, Shin-Ichiro|Shirabe, Ken|Shimada, Mitsuo|Wands, Jack R|Maehara, Yoshihiko
PMID: 12717393
Journal: World J Gastroenterol. 2010 Jan 14;16(2):156-66.
Title: Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
Author: Wolf, Samuel|Lorenz, Jana|Mossner, Joachim|Wiedmann, Marcus
PMID: 20066734
Journal: Anticancer Res. 2011 Oct;31(10):3289-99.
Title: Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.
Author: Thrum, Stephan|Lorenz, Jana|Mossner, Joachim|Wiedmann, Marcus
PMID: 21965739